The Effects of the JOBS Act on Biotech Startups » Medical Funding Professionals

The Effects of the JOBS Act on Biotech Startups

Deregulating Capital

The 2015 JOBS Act, including Regulation A+, is driving the biotech industry forward. IPO volume in biotech has more than doubled since 2015, now accounting for almost 40% of US IPOs. Biotech companies are getting to their IPOs faster, at higher valuations, and using the money to fund further R&D, and hiring to support it.

Deregulating capital is creating jobs and saving lives.

Deregulating Capital

Deregulating Innovation Capital: The Effects of the JOBS Act on Biotech Startups | CLS Blue Sky Blog

Under the JOBS Act, Congress and the SEC significantly reduced disclosure requirements and compliance costs for newly public companies.

© 2024 Medical Funding Professionals
Medical Funding Professionals is a registered investment advisor located in Nevada. Medical Funding Professionals and its representatives are in compliance with the current filing requirements imposed upon registered investment advisors by those jurisdictions in which Medical Funding Professionals maintains clients. Medical Funding Professionals may only transact business in those states in which it is registered or qualifies for an exemption or exclusion from registration requirements. Medical Funding Professionals’ web site is limited to the dissemination of general information pertaining to its advisory services. Accordingly, the publication of Medical Funding Professionals’ web site on the Internet should not be construed by any consumer and/or prospective client as either legal advice or Medical Funding Professionals’ solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation.